![Marc d'Abbadie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc d'Abbadie
Directeur/Bestuurslid bij
Spark Nw Carry Partner LLP
Profiel
Dr. Marc d'Abbadie is an Investment Director at SPARK Impact Ltd. He is on the Board of Directors at Dadu Investments Ltd., Nwf4b Directors Ltd., Spark Nw Carry Partner LLP and Videregen Ltd.
Dr. d'Abbadie was previously employed as a Non-Executive Director by Evgen Pharma Plc, a Non-Executive Director by Evgen Ltd., a Non-Executive Director by Absynth Biologics Ltd., a Non-Executive Director by EnXray Ltd., a Consultant by McKinsey & Co., Inc., and a Non-Executive Director by Zilico Ltd.
He received his graduate degree from Trinity College, Cambridge and a doctorate degree from the University of Cambridge.
Actieve functies van Marc d'Abbadie
| Bedrijven | Functie | Begin |
|---|---|---|
SPARK Impact Ltd.
 SPARK Impact Ltd. Investment ManagersFinance SPARK Impact invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, diagnostics, clinical research, analytical services & sciences, healthcare technologies and medical devices. It provides financing for early and growth stage capital requirements. | Private Equity Investor | - |
Videregen Ltd.
 Videregen Ltd. BiotechnologyHealth Technology Operates a regenerative medicine company created to address the chronic shortage of organs for transplantation | Directeur/Bestuurslid | - |
Spark Nw Carry Partner LLP | Directeur/Bestuurslid | - |
Nwf4b Directors Ltd. | Directeur/Bestuurslid | - |
Dadu Investments Ltd. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Marc d'Abbadie
| Bedrijven | Functie | Einde |
|---|---|---|
| THERACRYF PLC | Directeur/Bestuurslid | 08-11-2018 |
EnXray Ltd.
 EnXray Ltd. Information Technology ServicesTechnology Services Develops sterilization technology solutions for medical device manufacturing companies | Directeur/Bestuurslid | - |
Absynth Biologics Ltd.
 Absynth Biologics Ltd. BiotechnologyHealth Technology Develops and manufactures immunological prophylaxis, novel vaccines and therapies | Directeur/Bestuurslid | - |
Zilico Ltd.
 Zilico Ltd. BiotechnologyHealth Technology Develops a medical device to detect cervical cancer and pre-cancerous cells in the cervix | Directeur/Bestuurslid | - |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Marc d'Abbadie
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
10
Eerstegraads connecties
13
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
Evgen Pharma Plc
 Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trinity College, Cambridge
 Trinity College, Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Absynth Biologics Ltd.
Absynth Biologics Ltd. BiotechnologyHealth Technology Develops and manufactures immunological prophylaxis, novel vaccines and therapies | Health Technology |
Zilico Ltd.
Zilico Ltd. BiotechnologyHealth Technology Develops a medical device to detect cervical cancer and pre-cancerous cells in the cervix | Health Technology |
Evgen Ltd.
 Evgen Ltd. Medical/Nursing ServicesHealth Services Develops novel glucosinolate based products for the prevention and treatment of human disease | Health Services |
SPARK Impact Ltd.
SPARK Impact Ltd. Investment ManagersFinance SPARK Impact invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, diagnostics, clinical research, analytical services & sciences, healthcare technologies and medical devices. It provides financing for early and growth stage capital requirements. | Finance |
Videregen Ltd.
Videregen Ltd. BiotechnologyHealth Technology Operates a regenerative medicine company created to address the chronic shortage of organs for transplantation | Health Technology |
Spark Nw Carry Partner LLP | |
Nwf4b Directors Ltd. | |
Dadu Investments Ltd. | |
EnXray Ltd.
EnXray Ltd. Information Technology ServicesTechnology Services Develops sterilization technology solutions for medical device manufacturing companies | Technology Services |
Kies MarketScreener 
